Replies to post #691 on Bioxytran Inc (BIXT)

[Ecomike]

The SEC really screwed the Pooch on this one, and people died of Covid because of it IMO.

Huge news is out. $BIXT Patents on Steroids.

There is no excuse for OTC foot dragging on this. IMO. No excuse at all.

Biggest lie ever told: "We are with the Government, and we are here to help"

https://ih.advfn.com/stock-market/USOTC/bioxytran-pk-BIXT/stock-news/88339101/current-report-filing-8-k

10.69 Approval of International Patent WO2022/099052 - Polysaccharides for Use in Treating Sars-Cov-2 Infections, dated May 12, 2022.

10.70 Approval of International Patent WO2022/099061 - Polysaccharides for IV Administration that Treat SARS-CoV-2 Infections, dated May 12, 2022.

10.71 Official USPTO Notice of Publication under 12(A) for the Trademark ProLectin

Item 8.01 Other Events.

On May 12th, 2022, the International Bureau of the Patent Cooperation Treaty (PCT) approved and published two patent applications from Bioxytran, Inc.:

? WO 2022/099061 - Polysaccharides for Use in Treating Sars-Cov-2 Infections - The invention provides a method for treating SARS-CoV-2 by administering an effective amount of galactomannans to a subject in need thereof.

? WO2022/099061 - Polysaccharides for IV Administration that Treat Sars-Cov-2 Infections - The invention provides a method for treating SARS-CoV-2 by administering an effective amount of pectin polysaccharides to a subject in need thereof.

On June 8, 2022 United States Patent and Trademark Office (USPTO) approved the Trademark ProLectin to be published in the published in the Trademark Official Gazette (TMOG) on June 28, 2022.